3rd Drug Development Forum

October 1–3, 2018 | Hilton Boston Logan Airport Hotel

Executive-level networking for smarter partnerships and pipeline strategies, more effective development, and improved early research outcomes 

FIERCEBIOTECH DRUG DEVELOPMENT FORUM

Where industry leaders set partnership and pipeline strategy

The FierceBiotech Drug Development Forum is an incomparable networking venue where hundreds of biotech C-suite decision makers tackle the greatest problems the industry faces in business development and early R&D. 

Our all-new program features unprecedented depth on managing VC relationships, beating ambitious growth plans, developing your immuno-oncology business model, adapting to new regulatory and pricing realities, and maintaining competitive advantage after the next market downturn. 

VIEW SCHEDULE Group
Graphic 1

View the Full Agenda

Featuring 60+ C-suite Executives and 35+ sessions across 3 tracks
Group
Graphic 2

Join biotech leaders

Register now to benchmark & network with 300+ attendees
Group
Graphic 3

SPONSORSHIP OPPORTUNITIES

Share expertise, showcase your technologies, products & services
Group

2018 Featured Speakers

Girish Aakalu IPSEN, VP, Global Head of External Innovation
Girish Aakalu

VP, Global Head of External Innovation
IPSEN 

ROY BAYNES  Senior Vice President, Head of Clinical Development MERCK
Roy Baynes

CMO, Senior Vice President, Head of Clinical Development
MERCK

Lawrence Bloch President INFINITY PHARMACEUTICALS 
Lawrence Bloch

President
INFINITY PHARMACEUTICALS 

Ramzi Dagher
Ramzi Dagher

Vice President, Worldwide Safety and Regulatory, and Regulatory Head, Europe and International
PFIZER

Nouhad Husseini Vice President, Head of Business Development REGENERON
Nouhad Husseini

Vice President, Head of Business Development
REGENERON

Ravi Kiron Head, BioPharma External Innovation EMD SERONO 
Ravi Kiron

Head, BioPharma External Innovation
EMD SERONO 

Agustin Melian, Senior Vice President, Global Medical Sciences, ALEXION PHARMACEUTICALS
Agustin Melian

Senior Vice President, Global Medical Sciences
ALEXION PHARMACEUTICALS

Salim Mujais Senior Vice President, Global Therapeutics Head, Specialty Pharma ASTELLAS 
Salim Mujais

Senior Vice President, Global Therapeutics Head, Specialty Pharma
ASTELLAS 

Sridhar Ramaswamy Vice President, Translational R&D TESARO
Sridhar Ramaswamy

Vice President, Translational R&D
TESARO

Jeremy Sohn Vice President, Global Head of Digital Business Development & Licensing NOVARTIS
Jeremy Sohn

Vice President, Global Head of Digital Business Development & Licensing
NOVARTIS

2018 KEYNOTE SPEAKERS

KEYNOTE: Pursue Breakthrough Approvals in Multiple Global Markets 
TUESDAY, OCTOBER 2, 2018

MODERATOR: Eric Palmer, Editor, FIERCEMARKETS 

Ramzi Dagher, Vice President, Worldwide Safety and Regulatory; Regulatory Head, Europe and International, PFIZER

Martine Zimmerman, Senior Vice President, Global Regulatory Affairs, ALEXION PHARMACEUTICALS 

Roy Baynes, CMO, Senior Vice President, Head of Clinical Development, MERCK 

Maria Fardis, CEO, IOVANCE 

 

LEARN MORE Group

Fierce 15 winners: What does it take to be fierce in today's biotech market?

2018 SPONSORING ORGANIZATIONS